Ineos Styrolution to Buy Korean JV

Marking its first acquisition since Ineos took over the former joint venture with BASF, Ineos Styrolution has signed an agreement to buy the joint-venture K-Resin styrene-butadiene copolymers (SBC) business of Chevron Phillips Chemical Company and Daelim Industrial for an undisclosed sum. The purchase will comprise the equity interests in K R Copolymer Company (KRCC), which is owned 60% by Chevron Phillips Chemical and 40% by Daelim, as well as intellectual property for K-Resin and other assets related to the SBC business.

Once completed, the acquisition will allow Ineos Styrolution to supply its customers from production sites in Europe, the Middle East & Africa, the Americas and Asia-Pacific. The company said the deal underlines its commitment to its “Triple Shift” growth strategy, an initiative launched in 2013 to focus on higher-growth industries, styrenic specialties and standard ABS, along with emerging markets.

K-Resin SBC is complementary to Ineos Styrolution’s existing Styrolux and Styroflex SBC brands, expanding the company’s portfolio. “Our customers will benefit from our ability to supply and support their worldwide demand from our expanded geographic footprint, with SBC manufacturing and research and development centers in all major regions,” commented CEO Kevin McQuade.

KRCC’s SBC plant is located in Yeosu, on the southern coast of South Korea, some 175 kilometers from Ineos Styrolution’s plant in Ulsan. The transaction remains subject to the usual closing conditions and regulatory approvals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.